Welcome to the Journal

ISSN: 2041-6792 | *Journal Impact Factor: 2.75 | NLM ID: 101554582 Journal Membership services

Clinical Investigation (OACLI) (2041-6792) plays significant role in the diagnosis, therapy and cure of diseases apart from new drug development and delivery. The Clinical Investigation Journal offers an Open Access platform to the scholars, amateurs, clinical practitioners and students that are keen in contributing their findings in this field.

Clinical Investigation (OACLI) caters to the clinical drug development and methodology, facilitating rapid publication of research outcome on new drug data from human studies. The journal includes topics like safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. Also the journal publishes expert analysis of ongoing Phase I–IV trials and perspectives on how to run future trials.

The journal offers thoroughly reviewed original research as research articles, review articles, Clinical Trial Protocols, Clinical Trial Perspectives, Clinical Trial Outcomes, Clinical Trial Reports, Clinical Trial Methodologies, Clinical Trial phase I-IV findings, Commentaries on Clinical trials, case studies, commentaries, Short Communication, and Letters to the Editors in the areas not limited to Regulations and guidelines on drug development and delivery, legal and ethical issues of clinical trials, issues of testing of novel drugs, new medical procedure, new medical devices etc.

Submit your manuscripts online at Editorial Tracking online submission: https://www.scholarscentral.org/submissions/clinical-investigation.html

Contact Editorial Office or send attachment of manuscript at any of the following mail id: [email protected]

*2019 Journal Impact Factor was established by dividing the number of articles published in 2017 and 2018 with the number of times they are cited in 2019 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2017 and 2018, and 'Y' is the number of times these articles were cited in indexed journals during 2019 then, journal impact factor = Y/X

Recently Published Articles

Editorial

Clinical Investigation: Editorial

Author(s): Jennifer Stewart

I am pleased to mention that during the year 2019, all issues of volume 9 were published online well within the time and the print issues were also brought out and dispatched within 30 days ..

Review Article p. 177-184

Clinical impact potential of Rejuveinix (RJX) for prevention of fatal acute respiratory distress syndrome (ARDS) and multi-organ failure in COVID-19 patients

Author(s): Fatih M. Uckun*, Jim Ervin, Kazim Sahin, Joy Powell, Natalie Pizzimenti, Jackie Earabino, Hendrik van Wyk, Mariette van Wyk, Peter Pacult, Taha Koray Sahin, Kristina Cabala

RJX is an Intravenous (IV) formulation of known physiologically compatible compounds that is being developed for more effective supportive therapy of patients with sepsis, including COVID-19..

Relevant Topics

Recommended Conferences

International Conference on Clinical Trials and Case Reports

Toronto, Canada

4th International Conference on Toxicology and Clinical Toxicology

Dubai, United Arab Emirates
izmir bayan escort escort izmir bursa escort antalya escort kızlar izmir escort porno porno indir porno izle escort bartın escort burdur escort eskişehir havalandırma sistemleri porno izmir escort bursa escort porno izle indir izmir escort bayan